View in Browser

[link removed]

JOIN THE CONVERSATION

 

BREAST CANCER RESEARCH NEWS: WHAT YOU NEED TO KNOW
November 2020

 

[link removed]

FDA Approves Immunotherapy Keytruda for PD-L1-Positive Triple-Negative
Breast Cancer
Last week Keytruda was approved in combination with chemotherapy to
treat locally advanced or metastatic triple-negative, PD-L1-positive
breast cancer that can't be removed with surgery. Results from a
clinical trial showed that the treatment combination offered better
progression-free survival than chemotherapy alone.

READ

 

[link removed]

Breast Cancers Found Between Regular Screening Mammograms Seem More
Aggressive
Researchers looked at information from 69,025 women who were part of the
national breast cancer screening program in Manitoba, Canada, from
January 2004 to June 2010. According to the study, interval cancers were
more likely to have aggressive characteristics than breast cancers found
by routine screening.
Read

 

[link removed]

Study: Older Women With Early-Stage HER2-Positive Breast Cancer May Be
Able to Skip Chemotherapy
Researchers wanted to see if treating certain women aged 70 to 80 with
Herceptin alone after surgery offered the same benefits as treating them
with Herceptin plus chemotherapy because this age group has a higher
risk of side effects from chemotherapy.
Read

 

[link removed]

Better Survival for Early-Stage HER2-Positive Breast Cancer Linked to
Pathologic Complete Response to Targeted Therapy Before Surgery
Women diagnosed with early-stage HER2-positive breast cancer treated
with Herceptin and Tykerb before surgery who had a pathologic complete
response (pCR) had better survival than women who didn't have a pCR.
Read

 

[link removed]

Early Results Suggest Ibrance Plus Faslodex as First Treatment Improves
Outcomes for Metastatic Hormone-Receptor-Positive, HER2-Negative Breast
Cancer
The Ibrance and Faslodex treatment combination improved progression-free
survival compared to Faslodex alone, according to the FLIPPER study. The
early results are encouraging, but more research is needed to see if
this improvement translates into better overall survival.
Read

 

**The Breastcancer.org**

**research news update is sponsored by Lilly Oncology.**

 

[link removed]

Find more information about the latest breast cancer research news

on Breastcancer.org.

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

You subscribed to receive updates. If you no longer wish to be notified,
unsubscribe here .

Breastcancer.org, 120 East Lancaster Ave, Suite 201, Ardmore, PA 19003, United States
Breastcancer.org is a nonprofit 501(c)(3) organization.
_________________

Sent to [email protected]

Unsubscribe:
[link removed]

Breastcancer.org, 120 East Lancaster Ave, Suite 201, Ardmore, PA 19003, United States